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Scaffold proteins for MAP kinase (MAPK) signalling modules play an important role
in the specific and efficient signal transduction of the relevant MAPK cascades. Here,
we investigated the function of the scaffolding protein c-Jun NH2-terminal kinase
(JNK)-associated leucine zipper protein (JLP) by depleting it in cultured cells using
a short hairpin RNA (shRNA) against human JLP. HeLa and DLD-1 cells stably
expressing the shRNA showed a defect in cell migration. The re-expression of full-
length shRNA-resistant mouse JLP rescued the impaired cell migration of the JLP-
depleted HeLa cells; whereas, a C-terminal deletion mutant of mouse JLP, which
failed to bind the G protein Ga13, showed little or no effect on the cell migration
defect. Furthermore, although a constitutively active Ga13 enhanced the migration of
control HeLa cells, the Ga13-induced cell migration was significantly suppressed in
the JLP-depleted HeLa cells. Taken together, these results suggest that JLP
regulates cell migration through an interaction with Ga13.
Key words: cell migration, MAP kinase, p38, RNA interference, scaffold protein.
Abbreviations: DMEM, Dulbecco’s modified Eagle’s medium; EDTA, ethylenediaminetetraacetic acid; GST,
glutathione S-transferase; HEK, human embryonic kidney; JLP, JNK-associated leucine zipper protein;
JNK, c-Jun NH2-terminal kinase; JSAP1, JNK/stress-activated protein kinase-associated protein 1; KD,
knockdown; MAPK, MAP kinase; PCNA, proliferating cell nuclear antigen; PCR, polymerase chain
reaction; shRNA, short hairpin RNA.
MAP kinase (MAPK) cascades transmit signals through
the sequential phosphorylation and activation of three-
tier kinase modules, consisting of MAPK kinase kinase,
MAPK kinase and MAPK. Mammalian MAPK signalling
pathways play a key role in multiple cellular functions,
such as proliferation, migration and apoptosis (1, 2). The
specificity of MAPK signalling is mediated, at least in
part, by scaffold proteins. Scaffold proteins for MAPK
cascades organize the MAPK signalling components into
functional modules, thereby enabling the efficient activa-
tion of specific MAPK pathways (3–5). The scaffolding
complexes also protect the signalling components within
the relevant MAPK modules from undesired activation
by other signalling molecules in cells.
c-Jun NH2-terminal kinase (JNK)-associated leucine
zipper protein (JLP) was originally identified as a
binding protein for the transcription factor Max, and
further biochemical study indicated that JLP functions
as a scaffold protein for the JNK and p38 MAPK
signalling modules (6). JLP is broadly expressed, and is
structurally related to JNK/stress-activated protein
kinase-associated protein 1 (JSAP1 or JNK-interacting
protein 3), a scaffold protein for JNK cascades (7–9).
Studies of JLP have mainly focused on identifying its
interacting proteins, which include kinesin light chain 1
and Ga13, the a-subunit of the heteromeric G13 protein
(10, 11). JLP has also been reported to play an important
role in myogenesis by interacting with the cell-surface
protein Cdo (12). To date, however, the physiological
functions of JLP remain poorly understood.
Here, we established cultured cell lines expressing a
short hairpin RNA (shRNA) against JLP, in which JLP
expression was severely decreased, and we used these
JLP knockdown (KD) cells to investigate the function
of JLP.
MATERIALS AND METHODS
Cell Culture—HeLa cells (human cervical carcinoma),
DLD-1 cells (human colon carcinoma) and human
embryonic kidney (HEK) 293T cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM, Sigma,
St. Louis, MO, USA) containing 10% fetal bovine serum
(FBS) in a 5% CO2 atmosphere at 378C. For immunos-
taining and cell migration assays, HeLa cells were
cultured on plates coated with type I collagen (20 mg/ml;
Nitta Gelatin, Osaka, Japan). For JNK and p38 activa-
tion, HeLa cells were stimulated with UV-C irradiation or
anisomycin (3mg/ml, 5–15 min). In the UV-C irradiation
experiment, cells in a 35-mm dish were washed once with
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phosphate-buffered saline (PBS), the PBS was removed,
and the cells were exposed to UV-C light at 100 J/m2. The
cells were then incubated in medium for 5–15 min.
Expression Plasmids—The following annealed oligonu-
cleotides with hairpin sequences were inserted into AgeI/
EcoRI-digested pMKO.1-puro (13) for the expression of
shRNAs against JLP: JLP-shRNA1, forward, 50-CCGG
CTTGAGCTGAAAGCGAAAAACCTCGAGGTTTTTCGCT
TTCAGCTCAAGTTTTTG-30 and reverse, 50-AATTCAAA
AACTTGAGCTGAAAGCGAAAAACCTCGAGGTTTTTCG
CTTTCAGCTCAAG-30; JLP-shRNA2, forward, 50-CCGG
TGAAGATGCAAGGCAAAAAGCCTCGAGGCTTTTTGC
CTTGCATCTTCATTTTTG-30 and reverse, 50-AATTCAAA
AATGAAGATGCAAGGCAAAAAGCCTCGAGGCTTTTT
GCCTTGCATCTTCA-30, where the underlined letters
represent human JLP sequences (GenBank accession no.
AF327452). To generate the plasmid vector pBabe-blast,
the entire coding region of the blasticidin S-resistance gene
was amplified by polymerase chain reaction (PCR) using
pWZL-blast (14, 15) as a template, and the PCR product
was replaced with the puromycin-resistance gene in
pBabe-puro. The entire coding regions of Flag-tagged
mouse Rac1 and mouse Ga13 (RegSeq accession no.
NM_009007 and NM_010303, respectively) were obtained
by PCR and subcloned into BamHI/SalI-digested pBabe-
blast. To introduce nucleotide substitutions into cDNAs
encoding Ga13 and the small GTPase Rac1, to create
constitutively active forms of Ga13 (Ga13Q226L) and Rac1
(Rac1G12V), site-directed mutagenesis was carried out by
overlapping PCR as described previously (7). The region of
the cytomegalovirus promoter in the plasmid vector
pcDNA3 (Invitrogen, Carlsbad, CA, USA) was amplified
by PCR and inserted into pWZL-blast to generate pWZL-
CMV-blast. The coding regions of Flag-tagged mouse full-
length JLP (mJLP; residues 1–1307) and C-terminal
truncated JLP (mJLPC; residues 1–1164) were obtained
by PCR and subcloned into BamHI/XhoI-digested pWZL-
CMV-blast. The PCR product encoding the full-length
wild-type Ga13 was inserted into KpnI/XhoI-digested
pcDNA3-Flag (7) to generate pcDNA3-Flag-Ga13. The
coding regions of the full-length mJLP (residues 1–1307)
and mJLPC (residues 1–1164) were amplified by PCR
and inserted into HindIII (filled in)/XhoI-digested
pcDNA3.1-Hygro (Invitrogen) to generate pcDNA3-mJLP
and pcDNA3-mJLPC, respectively. To generate expres-
sion plasmids for JLP glutathione S-transferase (GST)
and His fusion proteins, the coding region of mJLP
(residues 796–955) was amplified by PCR and subcloned
into EcoRI/XhoI-digested pGEX4T-3 (GE Healthcare,
Buckinghamshire, UK) or NheI/XhoI-digested pREST-B
(Invitrogen). All the amplified sequences were verified by
DNA sequencing.
Antibodies—The GST-mJLP (residues 796–955) and
His-mJLP (residues 796–955) recombinant proteins
expressed in Escherichia coli were purified with glu-
tathione Sepharose (GE Healthcare) and Ni-NTA Agarose
(Qiagen, Hilden, Germany) according to the manufac-
turer’s instructions, respectively. The purified GST-JLP
protein was used for antiserum production in Kbl:JW
rabbits. The antiserum was absorbed serially on three
columns: an immobilized NHS-activated Sepharose
(GE Healthcare) column, which was made using whole
sonic extracts of E. coli, an immobilized GST-Sepharose
column, and a column bearing immobilized Flag-tagged
full-length JSAP1, which was obtained by transient
expression in HEK293T cells. The flow-though fraction
was further purified using an antigen-affinity column,
the His-mJLP-Ni-NTA Agarose column, and used as
the anti-JLP antibody in this study. Other primary
antibodies were as follows: mouse monoclonal anti-Flag
M2 (Sigma), rabbit polyclonal anti-actin (Sigma), mouse
monoclonal anti-a-tubulin (Sigma), mouse monoclonal
anti-proliferating cell nuclear antigen (PCNA; Dako,
Glostrup, Denmark), mouse monoclonal and rabbit poly-
clonal anti-phospho-JNK (Cell Signaling Technology,
Beverly, MA, USA), rabbit polyclonal anti-
phospho-p38 (Cell Signaling Technology) and mouse
monoclonal anti-paxillin (BD Biosciences, San Jose, CA,
USA) antibodies. The antibody to actin (cat. no. A5060)
shows a broad specificity with actin isoforms across a
range of organisms. The monoclonal and polyclonal anti-
phospho-JNK antibodies were used for immunoblotting
and immunofluorescence, respectively. Secondary anti-
bodies were goat Alexa fluor 488-conjugated anti-mouse
IgG and goat Alexa fluor 546-conjugated anti-rabbit IgG
antibodies (Invitrogen).
Virus Production—Recombinant retroviruses for the
expression of JLP-shRNA1 and JLP-shRNA2 were pre-
pared as described previously (16).
Screening of Cell Lines—HeLa cell lines stably expres-
sing JLP-shRNA1 and JLP-shRNA2 were screened in the
presence of puromycin as described previously (16). The
selected cell populations were subjected to immunoblot-
ting with the anti-JLP antibody. To obtain clones
expressing JLP-shRNA1, HeLa cells (1 106 cells/60-mm
dish) were infected with serially diluted recombinant
virus for JLP-shRNA1, and the cells were selected as
described previously (16). To establish cell lines stably
expressing full-length mJLP, mJLaC, Flag-Rac1G12V or
Flag-Ga13Q226L in a JLP KD HeLa clone, the cells were
split and plated onto 60-mm dishes (5 105 cells/dish) the
day before transfection, and the relevant expression
plasmids were introduced into the JLP KD HeLa cells
with LipoTrust SR (Hokkaido System Science, Sapporo,
Japan). Blasticidin S-resistant transfected cells were
selected using blasticidin S (Kaken, Tokyo, Japan) at a
concentration of 6 mg/ml.
Immunoblotting and Immunofluorescence—The pre-
paration of total cell lysates and subsequent immuno-
blotting analyses were carried out as described
previously (17). For cell fractionation experiments, cells
were harvested by trypsin-ethylenediaminetetraacetic
acid (EDTA), washed with PBS, resuspended in ice-cold
hypotonic buffer containing 10 mM HEPES pH 7.9,
1.5 mM MgCl2, 10 mM KCl, 0.5 mM dithiothreitol,
Protease Inhibitor Cocktail (Sigma), and Phosphatase
Inhibitor Cocktail (Sigma), and homogenized with 20
strokes in a Dounce homogenizer (tight pestle). After
centrifugation at 1,000g for 5 min at 48C, the super-
natant was used as the cytoplasmic fraction. The pellet
was washed twice with ice-cold hypotonic buffer, resus-
pended in nuclear extraction buffer containing 10 mM
Tris–HCl pH 7.4, 150 mM NaCl, 0.5% Nonidet P-40,
1 mM EDTA, Protease Inhibitor Cocktail (Sigma), and
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Phosphatase Inhibitor Cocktail (Sigma), and spun at
12,000g for 10 min at 48C. The supernatant was used as
the nuclear fraction. Immunofluorescence was performed
as described previously (16). Images were captured with
a confocal laser scanning microscope (LSM510; Zeiss,
Oberkochem, Germany).
Cell Migration Assay—To measure the cell migration
activity, Transwell and wound-healing assays were per-
formed. The Transwell cell migration assay was carried
out using a modified Boyden chamber (Corning, Corning,
NY, USA) containing a gelatin-coated polycarbonate
membrane filter (6.5-mm diameter, 8 mm pore size). The
upper surface of the filter was coated with type I collagen.
After serum starvation in DMEM containing 0.5% FBS for
12 h, cells (10,000 cells/100 ml) in DMEM with 0.5% FBS
were added to the upper chamber. The lower chamber
contained DMEM with either 10% FBS, or 0.5% FBS for
the constitutively active Rac1- and Ga13-induced migra-
tion assays, respectively. The cells were then incubated for
6 h at 378C in 5% CO2. Migratory cells on the underside
were detached by trypsinization and counted.
For the wound-healing assay, the cells were replated
onto dishes coated with type I collagen at a saturation
density (2.2 106 cells/35-mm dish) in the absence of
serum, and incubated for 3 h. They were then scratched
manually with a sterile pipette tip. After being washed
with DMEM, the wounded regions were allowed to heal
for 36 h in DMEM containing 10% FBS. The cell move-
ments were monitored using a BZ-8000 microscope
(Keyence, Osaka, Japan). Video images were collected
at 1 h intervals for 36 h, and the image stacks were
converted to QuickTime movies.
Statistical Analysis—Results are presented as the
meanSD from the number of experiments indicated
in the legends to Figs 3–5. Statistical differences were
analysed using Student’s t-test. Values of P< 0.05 were
considered to be statistically significant.
RESULTS AND DISCUSSION
Establishment of Stable HeLa Cell Lines Expressing an
shRNA Against JLP—To investigate the physiological
functions of JLP, we used the RNA interference (RNAi)
approach. We examined the effectiveness of two JLP-
shRNAs: JLP-shRNA1 and -shRNA2 (see MATERIALS
AND METHODS section). To this end, HeLa cells were
infected with the respective recombinant retroviruses,
selected in the presence of puromycin, and analysed by
immunoblotting. The expression level of JLP protein in
JLP-shRNA1-expressing cells was substantially decrea-
sed compared with the wild-type parent HeLa cells and
control HeLa (HeLactrl) cells that had been infected with
empty retrovirus (Fig. 1A; compare lanes 1, 2 and 3);
whereas, JLP-shRNA2 had little effect on the expression
of JLP (Fig. 1A, lane 4). Because the puromycin-resistant
cells infected with JLP-shRNA1 could be heterogeneous
with respect to JLP expression, we screened for inde-
pendent clones that barely expressed any JLP protein.
Indeed, the expression level of JLP protein was different
among clones (data not shown), and almost no expression
of JLP protein was observed in clones #1 and #6 (Fig. 1B,
lanes 2 and 3).
Immunocytochemical Analysis of Control and JLP KD
Cells—We noticed that clones #1 and #6 were morphol-
ogically distinct from the HeLactrl cells; notably, the cell
polarity seemed to be impaired in the JLP KD cells (data
not shown). We therefore analysed the focal adhesion of
the JLP KD cells by immunostaining. The shRNA-
mediated KD of JLP resulted in increases in the
number and size of paxillin-positive adhesions
(Fig. 2A). Furthermore, we found a portion of the JLP
protein in the HeLactrl cells to be localized to the leading
edge (Fig. 2B). Taken together, these results indicate
that JLP might play a role in cell migration.
Impairment of Cell Migration in JLP KD Cells—We
next examined the role of JLP in cell migration using
wound-healing and Transwell assays (Fig. 3). HeLactrl
cells migrating in scratch wound cultures showed wound
closure by 36 h; whereas, the pooled HeLa cells expres-
sing JLP-shRNA1 (HeLaJLP-shRNA1) and clones #1 and #6
showed retarded migration (Fig. 3A). We observed a
similar cell-migration defect in a JLP KD DLD-1 cell line
(data not shown), which had been established in the
same way as the HeLaJLP-shRNA1 cell line. For quantita-
tive analysis, we performed a Transwell assay (Fig. 3B).
Clones #1 and #6 as well as the HeLaJLP-shRNA1 cells
migrated 30% as efficiently as the HeLactrl cells (Fig. 3B,
























Fig. 1. Establishment of HeLa cell lines stably expressing
shRNA against JLP. (A) HeLa cells were infected indepen-
dently with recombinant retrovirus for JLP-shRNA1 and
-shRNA2, and selected with puromycin. Total cell lysates were
prepared from the cells, and subjected to immunoblotting with
an anti-JLP antibody. The wild-type (wt) parent HeLa cells, and
the control (ctrl) HeLa cells, which were infected with empty
retrovirus, were used as controls. Actin was used as a loading
control. The positions of the protein size markers are indicated
on the left. (B) The ctrl HeLa cells and JLP KD cells of clones #1
and #6, which were obtained after screening the pooled cells
infected with JLP-shRNA1-expressing retrovirus, were sub-
jected to immunoblotting with an anti-JLP antibody.
Representative results are shown.
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these JLP KD cells, and found no obvious difference
among the HeLactrl cells, the HeLaJLP-shRNA1 cells and
clones #1 and #6 (data not shown).
To confirm that the impaired cell migration was due to
the depletion of JLP, we re-expressed the wild-type full-
length mJLP or its deletion mutant mJLPC in clone #6.
The nucleotide sequence of mJLP cDNA corresponding to
JLP-shRNA1 is different from that of human JLP cDNA
at 3 out of 21 nucleotides, and thus mJLP mRNA could
be resistant to JLP-shRNA1. Indeed, we were able to
detect the expression of mJLP in clone #6, and the
protein levels of the stably expressing exogenous full-
length mJLP and mJLPC were similar to that of the
endogenous JLP in HeLactrl cells (Fig. 4A). As shown in
Fig. 4B, cell migration was rescued by the full-length
mJLP, but not by mJLPC, indicating that the impaired
migration was indeed due to the depletion of JLP, and
furthermore suggesting that the C-terminal region of
JLP is involved in the regulation of cell migration.
Involvement of Rac1 and G13 in JLP-mediated Cell
Migration—To investigate the molecular mechanism
underlying the JLP-mediated cell migration, we exam-
ined the involvement of Rac1 and Ga13, the latter of
which has been shown to interact with the C-terminal
domain of JLP (11). Consistent with the previous

























Fig. 3. Impairment of cell migration in JLP KD HeLa
cells. (A) The control (ctrl) HeLa cells, the pooled JLP KD HeLa
cells and clones #1 and #6 stably expressing JLP-shRNA1 were
replated onto collagen-coated dishes at a saturation density.
After being scratched, the wounded monolayers were allowed to
heal for 36 h. Scale bar, 200mm. Experiments were performed
independently three times, and representative results are
shown. (B) The cell migration activity of these cell lines was
quantified by a Transwell assay. Values represent the number of
migrated pooled KD, clone #1 and clone #6 cells as a percentage
of the number of control cells (meansSD from three indepen-










Fig. 2. Immunostaining analysis of the wild-type and JLP
KD HeLa cells. The control (ctrl) and JLP KD cells of clone #6
were cultured on collagen-coated dishes, then fixed and
immunostained for paxillin (A) and JLP (B). Scale bars, 20mm.
Representative photomicrographs are shown.
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observation by Kashef et al. (11), the deletion mutant
mJLPC, but not the full-length wild-type mJLP, failed
to bind Ga13 in a transient coexpression experiment in
HEK293T cells (Fig. 5A).
We next introduced expression plasmids for constitu-
tively active Rac1 (Rac1G12V) or Ga13 (Ga13Q226L)
mutants into the HeLactrl cells and clone #6, selected
the cells in the presence of blasticidin S, and analysed
the cell migration using a Transwell assay. The protein
levels of Rac1G12V stably expressed in the HeLactrl cells
and clone #6 were similar, as was the level of Ga13Q226L
(Fig. 5B). The expression of Rac1G12V or Ga13Q226L
resulted in a similar, significant enhancement of cell
migration in the HeLactrl cells (Fig. 5C). In contrast,
Rac1G12V and Ga13Q226L showed distinct effects on cell
migration in clone #6. Rac1G12V almost completely
rescued the defect in cell migration; whereas,
Ga13Q226L was unable to fully compensate for the
defect in these cells (Fig. 5C). Accordingly, clone #6
expressing Ga13Q226L showed a significant defect in cell
migration compared with the HeLactrl cells expressing
Ga13Q226L.
Considering the following three lines of evidence, our
results strongly suggest that JLP regulates cell
migration through an interaction with Ga13: (i) JLP KD
in HeLa and DLD-1 cells led to a defect in cell migration;
(ii) re-expression of the full-length wild-type JLP almost
completely rescued the impaired cell migration of the
JLP KD HeLa cells; whereas, the re-expression of
JLPC, which failed to bind Ga13, had little or no
effect on the defect in cell migration and (iii) expression
of a constitutively active Ga13 enhanced the migration of
the control HeLa cells, and the Ga13-induced cell
migration was significantly suppressed in the JLP KD
HeLa cells. On the other hand, a constitutively active
Rac1 fully compensated for the defective cell migration
regardless of the presence or absence of JLP protein,
suggesting that Rac1 acts downstream of JLP-Ga13
signalling, in which Ga13 activates Rac1 through the
relevant guanine exchange factors (18).
Altered Subcellular Distribution of Active p38 in JLP
KD Cells—Because JLP has been identified as a
scaffolding protein for JNK and p38 signalling (6), we
analysed the JNK and p38 in HeLactrl cells and clone #6
by immunoblotting and immunofluorescent staining
using antibodies against the phosphorylated, activated
forms of JNK (p-JNK) and p38 (p-p38). However, in the
absence of extracellular stimuli, the expression of p-JNK
and p-p38 was below detection level in both the HeLactrl
cells and clone #6 (data not shown). We therefore
examined whether the depletion of JLP perturbed the
normal activation and subcellular distribution of JNK
and p38 in response to stimuli. The expression levels of
p-JNK and p-p38 increased markedly after UV-C
irradiation and anisomycin treatment, and no obvious
difference in the expression level of p-JNK or p-p38 was
observed between the HeLactrl cells and clone #6
(Fig. 6A; data not shown). In contrast, the subcellular
distribution of p-p38 was different between UV-C-
irradiated clone #6 and HeLactrl cells (Fig. 6B and C).
After UV-C irradiation, immunofluorescent signals for
p-p38 were detected in both the nucleus and cytoplasm of
the HeLactrl cells, whereas almost all of the signal was in
the nucleus of clone #6 cells, and there was little or no
immunolabeling in the cytoplasm (Fig. 6B, a and b).
There were no obvious differences in the immunosignals
for p-p38 between the HeLactrl cells and clone #6 after
anisomycin treatment (Fig. 6B, c and d) or for p-JNK in
the control and JLP-depleted cells after UV-C irradiation
and anisomycin treatment (data not shown). We also
examined the subcellular distribution of p-p38 by
immunoblotting analysis, using cytoplasmic and nuclear
extracts prepared from the HeLactrl cells and clone #6
(Fig. 6C). The results were consistent with the data
obtained by immunocytochemical staining. That is, after
UV-C irradiation, p-p38 was detected in both the
cytoplasmic and nuclear fractions of the HeLactrl cells,
but it was only observed in the nuclear fraction of clone
#6 (Fig. 6C, lanes 2, 5, 8 and 11).
These immunocytochemical and immunoblotting
results strongly suggest that the scaffolding protein
JLP is involved, at least in part, in the regulation of
the subcellular distribution of active p38. Because
MAPKs, including p38, translocate upon activation
from the cytosol into the nucleus in many different

































Fig. 4. Requirement for JLP in cell migration. (A)
Expression plasmids for the full-length mJLP or mJLPC
were transfected into clone #6, and stable transfectants (#6 +
mJLP; #6 + mJLPC) were selected in the presence of
blasticidin S. Total cell lysates were prepared, and subjected
to immunoblotting with an anti-JLP antibody. Control (ctrl) and
clone #6 cells were used as positive and negative controls,
respectively. Actin was used as a loading control. Representative
results are shown. (B) Cell migration activity was quantified by
a Transwell assay. Values represent the number of migrated
stable transfectants as a percentage of the number of control
cells (meansSD from three independent experiments,
P< 0.01, Student’s t-test).
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translocation of active p38 and contribute to retaining a
portion of active p38 in the cytoplasm.
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cipitated (IP) with an anti-Flag antibody, and the immunopreci-
pitates were examined by immunoblotting using antibodies
against JLP and Flag (upper two panels). Expression of Flag-
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examined by immunoblotting (lower two panels). Experiments
were performed independently three times, and representative
results are shown. (B) Expression plasmids for Flag-Rac1G12V
and - Ga13Q226L were introduced into the control (ctrl) HeLa
cells or clone #6. Stable transfectants (ctrl + Rac1G12V;
#6 + Rac1G12V; ctrl + Ga13Q226L; #6 + Ga13Q226L) were selected
with blasticidin S. Total cell lysates were prepared, and subjected
to immunoblotting with an anti-Flag antibody. The white and
closed arrowheads indicate the positions of Flag- Ga13Q226L and
-Rac1G12V, respectively. The positions of protein size markers
are indicated on the left. Actin was used as a loading control. (C)
Cell migration activity was quantified by a Transwell assay.
Values represent the number of migrated stable transfectants as
a percentage of the number of control cells (meansSD from
three independent experiments, P< 0.01, Student’s t-test).
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Fig. 6. Altered subcellular distribution of active p38. (A)
Activation of p38 in response to stimuli in the control (ctrl) HeLa
cells and clone #6. Cells were stimulated with UV-C irradiation
(UV) or anisomycin (aniso) for the indicated time periods, and the
total cell lysates (20mg/lane) were analysed by immunoblotting
with an antibody against p-p38. Actin was used as a loading
control. (B) After stimulation of the ctrl HeLa cells and clone #6
with UV or aniso for 15 min, the cells were fixed and
immunostained for p-p38 (a–d). Phase-contrast photomicrographs
corresponding to the respective fluorescent micrographs are
shown in (e–h). Scale bar, 20 mm. (C) The ctrl HeLa cells and
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